Dana Genetic A/S: Financial statements 2020
CVR: 37298182
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
Dana Genetic A/S (CVR 37298182) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -471,623 and a net result of DKK -474,616 compared with DKK -490,214 the year before. Equity in the 2020 report amounted to DKK -2,616,210.
- Gross Profit
- DKK -471,623
- Profit/Loss
- DKK -474,616
- Equity
- DKK -2,616,210
- Total Assets
- DKK 236,524
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -472K | -475K | -2.6M | - |
| 2019 | - | -361K | -490K | -2.1M | - |
| 2018 | - | -639K | -876K | -1.7M | - |
| 2017 | - | -342K | -866K | -775K | - |
Official annual report
How creditworthy is Dana Genetic A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of November 20, 2020, REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Dana Genetic A/S.
About Dana Genetic A/S
Dana Genetic A/S was a Danish company of the type Aktieselskab based in Gentofte, founded in 2015. The company has been dissolved on 14 February 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2021, the company reported a gross profit of DKK -46,878 and a net result of DKK 37,646 compared with DKK -474,616 the year before. Equity in the 2021 report amounted to DKK -2,578,564.